There are two mRNA genes specified in this network (CDC25A and BIRC5) whose expression significantly correlated with upregulated miRNAs, namely hsa-mir-100 and hsa-mir-218-2, which are also known to be breast cancer drug targets (Figure S4A,B, Table S7). This evidence concerns the gene BIRC5 and breast cancer.